Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

AbCellera Biologics Inc (8QQ.SG)

2.1480
-0.0930
(-4.15%)
As of 8:05:11 AM GMT+2. Market Open.
Loading Chart for 8QQ.SG
  • Previous Close 2.2410
  • Open 2.1480
  • Bid 2.1760 x --
  • Ask 2.2140 x --
  • Day's Range 2.1480 - 2.1480
  • 52 Week Range 1.6505 - 3.8690
  • Volume 0
  • Avg. Volume 335
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8QQ.SG

View More

Performance Overview: 8QQ.SG

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8QQ.SG
22.57%
S&P 500 (^GSPC)
8.60%

1-Year Return

8QQ.SG
41.25%
S&P 500 (^GSPC)
6.00%

3-Year Return

8QQ.SG
71.23%
S&P 500 (^GSPC)
25.85%

5-Year Return

8QQ.SG
87.53%
S&P 500 (^GSPC)
89.51%

Compare To: 8QQ.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8QQ.SG

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    666.83M

  • Enterprise Value

    173.24M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    25.97

  • Price/Book (mrq)

    0.72

  • Enterprise Value/Revenue

    6.82

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8QQ.SG

View More

Company Insights: 8QQ.SG

Research Reports: 8QQ.SG

View More